ConductVision · Behavioral Analysis

Novel Object Recognition

Evaluate recognition memory with automated head-tracking exploration analysis.

RodentRecognition MemoryAuto Export
ConductVision / Novel Object Recognition
FamiliarNovel
Recording / Trial 3subject tracked
Discrimination Index0.35
Novel Exploration24s
Total Exploration42s

Key Parameters

Metrics automatically extracted by ConductVision.

Discrimination Index

(Novel - Familiar) / (Novel + Familiar) preference ratio

Recognition Index

Proportion of exploration devoted to the novel object

Novel Object Exploration

Total investigation time at the novel object

Familiar Object Exploration

Total investigation time at the familiar object

24.3s

Total Exploration Time

Combined investigation time at both objects

24.3s

Latency to Novel Object

Time to first contact with the novel object

+ 6 more parameters trackedShow all

Contact Frequency (Novel)

Number of approach bouts to the novel object

Contact Frequency (Familiar)

Number of approach bouts to the familiar object

Mean Bout Duration

Average length of individual investigation episodes

Locomotion

Total distance traveled during the test session

Time in Object Zones

Duration within proximity zones around each object

Familiarization Exploration

Exploration during the sample phase with identical objects

What is Novel Object Recognition?

Novel Object Recognition evaluates recognition memory by quantifying the difference in exploration time between familiar and novel objects. Animals with intact memory spend significantly more time investigating the novel object, providing a sensitive index of cognitive function.

ConductVision's automated head-tracking system precisely measures exploration time for each object, discrimination index, and recognition index. Up to four animals can be tracked simultaneously for moderate-throughput study designs.

Protocol Parameters

ParameterDescriptionDefault
Arena SizeOpen field arena for NOR testing40 × 40 cm (mouse) / 60 × 60 cm (rat)
Familiarization DurationSample phase with two identical objects5–10 min
Retention IntervalDelay between sample and test phases1 h (short-term) / 24 h (long-term)
Test DurationRecognition test with novel + familiar objects5 min
Minimum ExplorationMinimum total exploration for trial inclusion20 s (combined)
Exploration DefinitionCriterion for object investigationNose within 2 cm, oriented toward object
Object HeightObject size suitable for investigation8–12 cm
Object MaterialNon-porous, cleanable objectsGlass, ceramic, or plastic
Object CounterbalancingObject role alternation across subjectsNovel/familiar counterbalanced
Light IntensityOverhead illumination40–60 lux
Arena HabituationEmpty arena exposure before sample phase5–10 min, day before

Interpreting Results

Decreased Discrimination Index

Impaired recognition memory — DI near zero indicates failure to distinguish novel from familiar, seen in scopolamine model and Tg2576 Alzheimer's mice.

Reduced Novel Object Exploration

Memory deficit or anhedonia — less investigation of the novel object despite intact total exploration suggests recognition failure.

Decreased Total Exploration

Motivational or motor confound — low overall exploration invalidates DI calculation; trials below minimum threshold should be excluded.

Increased Latency to Novel Object

Neophobia or anxiety — delayed approach to the novel object may indicate anxiety-like behavior rather than memory deficit.

Enhanced Discrimination at 24h

Improved long-term recognition memory — DI improvement at 24h vs 1h delay seen with cognitive enhancers (donepezil, modafinil).

DI Decline from 1h to 24h

Impaired memory consolidation — normal short-term but impaired long-term recognition indicates consolidation-phase vulnerability.

Research Applications

Cognitive Enhancement

  • Cholinergic drugs — donepezil and galantamine rescue of scopolamine-induced NOR deficit
  • Nootropics screening — modafinil, racetams, and phosphodiesterase inhibitors
  • Memory consolidation — protein synthesis inhibitors and CREB pathway modulators

Neurodegeneration

  • Alzheimer's models — Tg2576, APP/PS1, and 5xFAD recognition memory deficits
  • Perirhinal cortex function — NOR is perirhinal-dependent, complementing hippocampal spatial tasks
  • Aging — age-related recognition memory decline across rodent strains

Psychiatric & Neurodevelopmental

  • Schizophrenia — PCP and MK-801 models with NOR deficits reversed by atypical antipsychotics
  • Traumatic brain injury — recognition memory as a sensitive cognitive endpoint post-injury
  • Prenatal stress — maternal stress effects on offspring recognition memory

Ready to automate your behavioral analysis?

Request a demo or contact our team to discuss how ConductVision can accelerate your research.